Article citationsMore>>
Schwartz, G.K., Robertson, S., Shen, A., et al. (2009) A Phase I Study of XL281, a Selective Oral RAF Kinase Inhibitor, in Patients (Pts) with Advanced Solid Tumors. Journal of Clinical Oncology, 27, 3513-3513.
has been cited by the following article:
Related Articles:
-
Satoki Nakamura, Tomohiro Yagyu, Tomonari Takemura, Lin Tan, Yasuyuki Nagata, Daisuke Yokota, Isao Hirano, Kiyoshi Shibata, Michio Fujie, Shinya Fujisawa, Kazunori Ohnishi
-
Mark S. Walker, Lee S. Schwartzberg, Diana M. Chen, D. Devi Ramanan, Arthur C. Houts, Carolina Reyes
-
Masanori Hotchi, Hiroshi Okitsu, Murato Miura, Madoka Hamada, Yasuhide Sonaka, Yoh Fukuda, Tsutomu Ando, Shinji Kuratate
-
Matthew H. Taylor, Alan Sandler, Walter J. Urba, Antonio M. P. Omuro, Greg S. Gorman, Rashida A. Karmali
-
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski